The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.

As the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

commonly known by brand names Ozempic and Wegovy, has the ability to counter metabolic dysfunction-associated steatohepatitis, or MASH, liver disease and some of its risk factors. MASH is ...

How does Wegovy (or any form of 2.4 mg dose of semaglutide ... Patient education: Metabolic dysfunction-associated steatotic liver disease (Beyond the Basics). UpToDate.